Phase I Study Of Intravenous DOTAP:Cholesterol-Fus1 Liposome Complex (DOTAP:Chol-fus1) In Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Chemotherapy (Protocol #0201-513)

Protocol #0201-513: Collaborators

GENE-BASED THERAPY

TIMING OF GENETIC CHANGES IN PRENEOPLASTIC LESIONS

PPT Slide

PPT Slide

EFFECTS OF 3p21.3 GENE EXPRESSION ON NSCLC CELLS AND NORMAL HUMAN BEC GROWTH

INDUCTION OF APOPTOSIS IN AD-3p21.3 GENE-TRANSDUCED CELLS

PPT Slide

PREDICTED SECONDARY STRUCTURE AND FUNCTIONAL DOMAINS OF FUS1 PROTEIN

MYRISTOYLATION OF FUS1 PROTEIN IN H1299 CELLS

IMMUNOHISTOCHEMICAL STAINING OF HUMAN NORMAL LUNG AND LUNG CANCER TISSUES WITH ANTI-Fus1 ANTIBODIES

STRUCTURE OF DOTAP-Chol-DNA COMPLEX